CD274 and neoplasm: On the basis of the presence of microsatellite instability and programmed death-ligand 1 (PD-(L)1) expression on patients with EC, and the CheckMate-577 trial results, adjuvant immunotherapy has been suggested in patients with residual tumor.2,3 However, there is still a gap in understanding the TME interaction with nCRT in EC.